Raia Drogasil (OTCMKTS:RADLY) Stock Rating Upgraded by Zacks Research

Key Points

• Zacks Research upgraded Raia Drogasil (OTCMKTS:RADLY) to a hold rating, and the stock traded up about 6.5% after the note.
• Raia Drogasil is a leading Brazilian retail pharmacy operator formed by the 2011 merger of Droga Raia and Drogasil, offering prescription and OTC medications, personal care products and in-store health services.
• Shares opened at $4.95, with a 12-month range of $2.17 to $5.34 and 50-day/200-day moving averages of $4.75 and $4.36, respectively.

Raia Drogasil (OTCMKTS:RADLY - Get Free Report) was upgraded by stock analysts at Zacks Research to a "hold" rating in a research note issued to investors on Thursday,Zacks.com reports.

Raia Drogasil Trading Up 6.5%

Shares of Raia Drogasil stock opened at $4.95 on Thursday. Raia Drogasil has a 12-month low of $2.17 and a 12-month high of $5.34. The business's 50 day moving average is $4.75 and its 200-day moving average is $4.36.

Raia Drogasil Company Profile

Raia Drogasil SA is a leading Brazilian retail pharmacy operator, offering a comprehensive range of prescription and over-the-counter medications, health and wellness products, personal care and beauty items, as well as a selection of convenience goods. The company’s network of stores operates under the Raia and Drogasil banners, serving diverse consumer needs across major urban centers. Complementary services include in-store prescription dispensing, compounding pharmacies and health screening programs such as blood pressure and glucose monitoring.

The company was formed in 2011 through the merger of two established Brazilian pharmacy chains, Drogasil and Droga Raia, each with origins dating back several decades.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.